150 related articles for article (PubMed ID: 2305613)
1. Neuromuscular effects of isoflurane in patients with myasthenia gravis.
Nilsson E; Muller K
Acta Anaesthesiol Scand; 1990 Feb; 34(2):126-31. PubMed ID: 2305613
[TBL] [Abstract][Full Text] [Related]
2. Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis.
Nilsson E; Paloheimo M; Müller K; Heinonen J
Acta Anaesthesiol Scand; 1989 Jul; 33(5):395-401. PubMed ID: 2800976
[TBL] [Abstract][Full Text] [Related]
3. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
Kadosaki M; Enzan K; Horiguchi T; Komatsu H; Suzuki M
Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis: relation between jitter in single-fiber EMG and antibody to acetylcholine receptor.
Konishi T; Nishitani H; Matsubara F; Ohta M
Neurology; 1981 Apr; 31(4):386-92. PubMed ID: 6261187
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
8. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
Namba T; Nakata Y; Grob D
Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
[TBL] [Abstract][Full Text] [Related]
9. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis.
Itoh H; Shibata K; Nitta S
Br J Anaesth; 2001 Dec; 87(6):885-9. PubMed ID: 11878691
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
Fambrough DM; Drachman DB; Satyamurti S
Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of myasthenia explained.
Verschuuren JJ; Palace J; Gilhus NE
Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
[TBL] [Abstract][Full Text] [Related]
12. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
13. Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis.
Nilsson E; Meretoja OA
Anesthesiology; 1990 Jul; 73(1):28-32. PubMed ID: 1972873
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of myasthenia gravis.
Drachman DB
Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
[No Abstract] [Full Text] [Related]
16. The relationship between anti-acetylcholine receptor antibody levels and neuromuscular function in chronically myasthenic rats.
Gallant PE
J Neurol Sci; 1982 Apr; 54(1):129-41. PubMed ID: 6281392
[TBL] [Abstract][Full Text] [Related]
17. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.
Lefvert AK; Pirskanen R; Svanborg E
J Neuroimmunol; 1985 Jul; 9(1-2):41-53. PubMed ID: 4008636
[TBL] [Abstract][Full Text] [Related]
18. The biology of myasthenia gravis.
Drachman DB
Annu Rev Neurosci; 1981; 4():195-225. PubMed ID: 7013636
[No Abstract] [Full Text] [Related]
19. Myasthenia and the neuromuscular junction.
Gilhus NE
Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
[TBL] [Abstract][Full Text] [Related]
20. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.
de Crousaz G; Fulpius BW
Lancet; 1978 Jan; 1(8054):47. PubMed ID: 74528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
